Aion Therapeutic (XCNQ:AION) Total Debt per Share : C$0.01 (As of Jan. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Total Debt per Share?

C$0.01 (As of Jan. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Aion Therapeutic's Total Debt Per Share for the quarter that ended in Jan. 2025 was C$0.01.

Aion Therapeutic Total Debt per Share Historical Data

The historical data trend for Aion Therapeutic's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Total Debt per Share Chart

Aion Therapeutic Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Total Debt per Share

Get a 7-Day Free Trial

0.03

0.01

Aion Therapeutic Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Total Debt per Share	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Aion Therapeutic Total Debt per Share Calculation

Aion Therapeutic's Total Debt Per Share for the fiscal year that ended in Apr. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.00	+	2.08)	/	411.55
	=	0.01

Aion Therapeutic's Total Debt Per Share for the quarter that ended in Jan. 2025 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.00	+	2.81)	/	497.15
	=	0.01

Aion Therapeutic Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.

Executives

Ismail Abdul Fattah	Director or Senior Officer of 10% Security Holder
Douglas Craig Wilson	Director or Senior Officer of 10% Security Holder
John Graham Simmonds	Director, Senior Officer

Aion Therapeutic Headlines

No Headlines